Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down - Should You Sell?

Key Points

• Shares gapped down — ALHC opened sharply lower (from $22.54 to $21.12) and traded around $19.83 after a Q1 beat, as investors reacted negatively to guidance that was only in‑line with expectations and profit‑taking drove a large selloff.
• Mixed analyst backdrop — some firms upgraded the stock (Zacks to "strong‑buy", Piper Sandler lifted its target to $30) but consensus is a "Moderate Buy" with an average price target of about $24.89 and several hold/sell views remain.
• Fundamental and insider caution — the company shows a negative PE, near‑zero net margin and negative ROE with a debt/equity of 1.80, and insiders sold roughly 1.47 million shares (~$28.7M) over the past three months.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $22.54, but opened at $21.12. Alignment Healthcare shares last traded at $19.8320, with a volume of 1,866,182 shares.

More Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Q1 beat on both EPS and revenue and showed year‑over‑year top‑line growth and margin improvement — evidence management cited for “disciplined growth.” Q1 Results Release
• Positive Sentiment: Analyst sentiment improved: Zacks upgraded ALHC from “hold” to “strong‑buy,” which supports upside conviction among some investors. Zacks Upgrade
• Neutral Sentiment: Company issued Q2 and FY2026 revenue guidance roughly in line with Street expectations (Q2 ≈ $1.3B; FY ≈ $5.2B) — guidance appears conservative/stable rather than above‑consensus upside. Press Release / Guidance
• Neutral Sentiment: Technical commentators pointed to a bullish pennant heading into earnings (possible breakout if momentum continues), which may moderate near‑term trading volatility. Technical Preview
• Negative Sentiment: Despite the beat, shares fell sharply in after‑hours trading (reports of ~10% decline) — market reaction suggests investors were disappointed by guidance that only matched estimates, near‑zero net margin/negative ROE metrics, or took profits after a run‑up. Shares Fall After‑Hours
• Negative Sentiment: High intraday and after‑hours volume accompanied the pullback, indicating distribution by some holders; balance‑sheet/valuation multiples remain points of focus (negative PE, debt levels). Market Reaction Coverage

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Zacks Research upgraded Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Piper Sandler lifted their target price on Alignment Healthcare from $20.00 to $30.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 6th. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research report on Friday, January 30th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Alignment Healthcare in a research report on Monday, April 20th. Finally, Wall Street Zen lowered Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, March 7th. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $24.89.

Alignment Healthcare Price Performance

The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71. The company has a 50-day simple moving average of $19.38 and a two-hundred day simple moving average of $19.42. The stock has a market capitalization of $4.25 billion, a price-to-earnings ratio of -2,049.65, a price-to-earnings-growth ratio of 4.46 and a beta of 1.20.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The firm had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.22 billion. During the same period last year, the company earned ($0.05) earnings per share. The firm's revenue for the quarter was up 33.3% on a year-over-year basis. On average, equities research analysts predict that Alignment Healthcare, Inc. will post 0.13 earnings per share for the current year.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $20.87, for a total value of $626,100.00. Following the sale, the president directly owned 1,028,813 shares of the company's stock, valued at $21,471,327.31. This trade represents a 2.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Andreas P. Wagner sold 11,602 shares of the stock in a transaction on Thursday, March 19th. The stock was sold at an average price of $18.22, for a total value of $211,388.44. Following the completion of the sale, the insider directly owned 148,628 shares in the company, valued at $2,708,002.16. This represents a 7.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 1,474,097 shares of company stock valued at $28,679,550 over the last three months. 7.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Alignment Healthcare

Large investors have recently added to or reduced their stakes in the stock. Summit Securities Group LLC bought a new stake in Alignment Healthcare during the 4th quarter valued at $26,000. Parallel Advisors LLC raised its stake in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company's stock valued at $33,000 after acquiring an additional 773 shares in the last quarter. Larson Financial Group LLC bought a new stake in Alignment Healthcare during the 3rd quarter valued at $33,000. First Horizon Corp bought a new stake in Alignment Healthcare during the 4th quarter valued at $39,000. Finally, GAMMA Investing LLC raised its stake in Alignment Healthcare by 83.8% during the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company's stock valued at $43,000 after acquiring an additional 987 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.